Fabrinet proffered guidance for its current (fourth) quarter, forecasting that it will book revenue of $860 million to $900 ...

Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago. These ...

Analyst revises estimates for NVTS after in line Q1 results, with $14.02M sales beating estimated $13.99M. Q2 sales expected at $14M-$15M vs consensus $14.95M.

Cytokinetics (CYTK) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.41. This compares to loss of $1.33 per share a year ago. These figures are ...

Rivian (RIVN) posted first quarter revenue of $1.24 billion, which topped the Bloomberg consensus estimate of $981.2 million.

lululemon faces significant tariff headwinds, potentially impacting margins by $280 million to nearly $1 billion, depending ...

Smucker (SJM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Duke Energy reported first-quarter 2025 earnings that surpassed analyst expectations, driven by higher rates and increased ...

U.S. enterprise demand is voracious for the company's artificial intelligence (AI)-powered software platforms.

Dutch healthcare technology company Philips on Tuesday cut its profit margin forecast for 2025, citing a net impact from ...

Stocks fell Monday for the first time in two weeks as another heavy week of earnings reports kicked off, while investors ...

It was a mixed second quarter for Tyson Foods, which saw net income of $380 million, and adjusted earnings of 92 cents per ...